CRCT - Centre de Recherches en Cancérologie de Toulouse
  • Center
    • Discover the Center
    • CRCT News
    • Annual report
    • Governance
    • Institutions and partners
    • Support services
    • The Scientific Events Committee
    • Directory
    • Publications
    • Events
    • Contact & Map
  • Research
    • Research lines and medico-scientific programs
      • General presentation medico scientific programs
      • Research lines
      • Medico-scientific programs
    • Research teams
      • 01 M. Ayyoub
      • 02 M.J. Pillaire
      • 03 G. Favre
      • 04 T. Levade / N. Andrieu
      • 05. S.Millevoi
      • 06 S. Pyronnet / C. Bousquet
    •  
      • 07 P. Brousset / F. Meggetto
      • 08 S.Manenti
      • 09 J.J. Fournié
      • 10 P. Cordelier
      • 11 E. Cohen-Jonathan Moyal / C. Toulas
      • 12 M. Poirot / S. Silvente-Poirot
      • 13 H. Avet-Loiseau / L. Martinet
    •  
      • 14 E. Chatelut
      • 15 M. Bardiès
      • 16 E. Delabesse
      • 17 J. Guillermet-Guibert / J.P. Delord
      • 18 J.E. Sarry
      • 19 F. Chibon
      • 20 S. Valitutti
      • 21 V. Pancaldi
  • CRCT/IUCT-O’s Programs
    • General aims of the programs
    • Our ongoing programs
  • Technology
    • General presentation technology
    • Technology Cluster’s website
  • Fr
  • En
Select Page
Focus: collaboration between Pierre Cordelier’s team & Neovirtech on oncolitic viruses

Focus: collaboration between Pierre Cordelier’s team & Neovirtech on oncolitic viruses

by Sébastien Guibert | 3 Apr 2018 | General news, Research

Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer....
Focus: IMMUSPHINX program – Targeting sphingolipid metabolism to improve the efficacy of immunotherapies in melanoma

Focus: IMMUSPHINX program – Targeting sphingolipid metabolism to improve the efficacy of immunotherapies in melanoma

by Sébastien Guibert | 22 Mar 2018 | General news, Research

Thanks to anticancer immunotherapies targeting immune checkpoints, the proportion of patients with metastatic melanoma (MM) in remission after 5 years has tripled during the last years. However, therapeutic options are sparse for patients who do not respond to...
Focus on “PhD PI3K Biology in health in disease” program

Focus on “PhD PI3K Biology in health in disease” program

by Sébastien Guibert | 29 Nov 2017 | Research

The program “PhD PI3K Biology in Health in Disease”, funded by the European Union (Horizon 2020 / Marie Sklodovska-Curie Program), aims to train the next generation of experts in the field of PI3Ks through the establishment of a European network of PhD...
Next Entries »

News

  • Role of sphingosin kinase 1 in cancer immunotherapy
  • New therapeutic perspectives for dendrogenin A, a cholesterol-derived metabolite
  • LungPredict: improve and personalize immuno-therapies
  • Three major stakeholders of the Oncopole form a strategic public-private sector alliance to boost innovation in oncology on the Toulouse campus
  • Trois acteurs majeurs de l’Oncopole concluent une alliance stratégique public-privé pour dynamiser l’innovation en cancérologie sur le campus toulousain

Events

  1. Conférence CRCT : Pr Angelo Parini – I2MC Toulouse : Sénescence cellulaire, fragilité, vieillissement: les enjeux des cohortes INSPIRE

    March 6 @ 11:00 - 12:00

  2. Conférence CRCT : Dr Camille Lobry Institut Gustave Roussy, Paris : Non-coding genome and epigenetic regulation of transcription in leukemia

    March 27 @ 11:00 - 12:00

View All Events

  • Contact & Map
  • Legal statements
  • RSS
© Conception & Design Agence CosiWeb
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site. Si vous continuez à utiliser ce dernier, nous considérerons que vous acceptez l'utilisation des cookies.Ok